Sanofi’s IGM Biosciences IGMS Stock Holding History

Sanofi’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,438,975	Closed	-$1.61M	–	10
2025 Q2	$1.61M	Hold	1,438,975	–	–	0.92%	9
2025 Q1	$1.65M	Hold	1,438,975	–	–	1%	7
2024 Q4	$8.79M	Buy	+1,438,975	New	+$17.1M	5.04%	5

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Sanofi's IGMS Position: Q3 2025 in Review

Sanofi sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 1,438,975 shares — an estimated $1.61M sold.

Sanofi first reported a position in IGMS in Q4 2024 and held it in 3 quarters. The position peaked at $8.79M in Q4 2024. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Sanofi reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Sanofi sold 1,438,975 IGM Biosciences shares in Q3 2025, an estimated $1.61M.
Sanofi first reported a position in IGM Biosciences in Q4 2024 and held it in 3 quarters.
Sanofi's IGM Biosciences position peaked at $8.79M in Q4 2024.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Sanofi's 13F filing for Q3 2025, filed 4 Nov 2025.